Patents
Patents for C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium (663)
09/2004
09/30/2004WO2004082604A2 Phosphoric ester demulsifier composition
09/28/2004US6797182 To remove oxygen and water; for semiconductors
09/16/2004US20040180969 Phosphoric ester demulsifier composition
09/16/2004US20040180947 Sulfonamide compounds and pharmaceutical use thereof
09/14/2004US6790957 Converting tertiary hydroxy group of a triazole antifungal compound into a phosphate group to improve aqueous solubility
09/10/2004WO2004076465A2 Silyl acrylate and poss compositions used in microlithographic processes
09/09/2004US20040176615 Forming calcium salt from ester
09/09/2004US20040176327 Use of bisphosphonic acids for treating angiogenesis
08/2004
08/31/2004US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation
08/17/2004US6777552 From an ester derivative or protected ester derivative of the statin by using calcium hydroxide
08/10/2004US6774121 Phospholipid prodrugs of anti-proliferative drugs
08/05/2004WO2004065396A2 Phosphoric esters of polyisobutene-substituted aromatic hydroxy compounds
07/2004
07/29/2004DE10302626A1 New polybutylphenyl phosphate esters, used e.g. as surface modifier, corrosion inhibitor, dispersant or adhesion promoter, are prepared by corresponding phenol with phosphorus oxyhalide and optionally water, alcohol, thiol or amine
07/21/2004EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite
07/14/2004EP1169326B1 Process for preparing alendronic acid
07/13/2004US6762317 Method for preparing formylphosphonic acid
07/01/2004US20040127363 Pesticidal compositions containing silicon compounds
06/2004
06/24/2004WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
06/24/2004US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds
06/17/2004US20040112375 Predicting outcome of hyperbaric oxygen therapy treatment with nitric oxide bioavailability
06/03/2004WO2004046155A2 Predicting outcome of hyperbaric oxygen therapy treatment with nitric oxide bioavailability
05/2004
05/19/2004EP0781136B1 Compounds and methods for the treatment of cancer
03/2004
03/31/2004CN1143668C Ascorbyl-phosphoryl-cholesterol
03/16/2004US6706896 Process for selective derivatization of taxanes
03/11/2004WO2003091264A3 Non nucleoside reverse transcriptase inhibitors
03/11/2004DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity
03/03/2004CN1140531C Method for manufacturing phosphine compound
02/2004
02/24/2004US6696601 Bone disorders
02/18/2004EP0918781B1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands
02/11/2004EP1003754B1 Method of manufacturing phosphine compound
02/05/2004US20040022866 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine
01/2004
01/27/2004US6683079 Reverse transcriptase inhibitors
12/2003
12/17/2003EP1370142A2 Pesticidal compositions containing silicon compounds
12/17/2003EP1283842B1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
11/2003
11/27/2003US20030220303 GABAB Receptor Agonists; used to treat gastrointestinal disorders, especially GERD
11/19/2003EP1235832B1 Vitamin d prescursors, method and intermediates
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/05/2003CN1126755C Process for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide
10/2003
10/28/2003US6638956 Pesticidal 1-arylpyrazoles
10/21/2003CA2098020C Anti-viral compounds
10/15/2003CN1448142A Compositions comprising cytosine derivatives for the treatment of cancer
10/09/2003US20030191092 MMP inhibitors
09/2003
09/09/2003US6617339 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/2003
07/31/2003US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/31/2003US20030144251 Pesticidal 1-arylpyrazoles
07/31/2003US20030144250 Triazole derivatives useful in therapy
07/24/2003WO2003059921A1 Mmp inhibitors
07/24/2003CA2470649A1 Mmp inhibitors
07/03/2003US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases
06/2003
06/19/2003US20030114706 Aminomethylphosphonic acid is contacted with water, an alcohol, a phenol and an oxidizing gas in the presence of a catalyst
06/19/2003US20030114685 Processes for preparing calcium salt forms of statins
06/18/2003CN1425078A Process for purification of organometallic compounds or heteroato mic organic compounds with a catalyst based on iron and manganese supported on zeolites
06/18/2003CN1425077A Process for purification of organometallic compounds or heteroatomic getter alloys
06/18/2003CN1425019A Vitamin D Precursors, preparation and intermediates thereof
06/18/2003CN1111409C Use of cytosine in preparation of medicines for treatment of cancers
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/03/2003US6573401 Reacting 4-aminobutyric acid with a phosphonation mixture of phosphorous acid and methanesulfonic anhydride, hydrolyzing the resulting reaction product, isolation by an appropriate pH adjustment, free acid or monosodium salt
05/2003
05/28/2003EP1313748A1 Compositions comprising dimeric or oligomeric ferrocenes
05/08/2003US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
04/2003
04/23/2003EP1205484B1 Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt
04/09/2003CN1409716A New amino propylphosphinic acid
04/03/2003US20030065214 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
03/2003
03/26/2003CN1103778C Compound containing alkoxyl silicane group and nexyl-inner-ureide group
03/05/2003EP0744396B1 Novel complex salts of phosphoric and amino acids and ruminant feed additive composition containing the same
02/2003
02/27/2003US20030038082 Process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys
02/19/2003EP1283842A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
02/11/2003US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein,
01/2003
01/15/2003EP1274879A1 A process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys
01/14/2003CA2288760C Ascorbyl-phosphoryl-cholesterol
01/09/2003US20030009046 Preparation of preparing substituted indanones
01/02/2003US20030003147 Effer-vescent bisphosphonate formulation
12/2002
12/31/2002US6500850 Pesticidal 1-arylpyrazoles
12/11/2002CN1384749A Use of diphophonic acid in treatment of vasculogenesis
12/10/2002US6492539 Preparation of preparing substituted indanones
11/2002
11/14/2002US20020168427 Plant extract
10/2002
10/24/2002US20020156053 Treating gastro-oesophageal reflux disease
10/22/2002US6469146 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
10/03/2002US20020142996 Use of bisphosphonic acids for treating angiogenesis
09/2002
09/18/2002EP1240172A1 New aminopropylphosphinic acids
09/17/2002US6451822 3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases
09/11/2002EP0912583B1 Ligands for asymmetric catalysis
09/04/2002EP1235832A1 Vitamin d prescursors, method and intermediates
07/2002
07/25/2002US20020099212 Sulfonamide compounds and pharmaceutical use thereof
07/17/2002EP1222927A2 Pharmaceutical compositions having appetite suppressant activity
07/03/2002EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs
06/2002
06/19/2002EP0980354B1 Vitamin d3 analogs with bis c-20 side chains
06/13/2002WO2001067863A3 Pesticidal compositions containing silicon compounds
06/12/2002EP1213020A2 Pharmaceutical compositions having appetite suppressant activity
06/12/2002EP0880533B1 Triazole derivatives useful in therapy
06/11/2002CA2240777C Triazole derivatives useful in therapy
05/2002
05/22/2002EP1169326A4 Process for preparing alendronic acid
05/22/2002CN1350540A Process for preparing amine platinum complexes
05/22/2002CN1085213C Triazole derivatives useful in therapy
05/15/2002EP1205484A1 Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt
05/02/2002US20020052527 Novel process for preparing alendronic acid
04/2002
04/23/2002US6376657 Pharmaceutical compositions having appetite suppressant activity
1 2 3 4 5 6 7